APOE and Alzheimer disease: Thus, to create a disease model that better mimics the neuropathological hallmarks of early-onset AD in vitro, an isogenic hiPSC line harboring the polymorphism ApoE4 has been generated through CRISPR-Cas9 modification (Lin et al., 2018; Park et al., 2021).